Alumni News '03 Michael A. Gentile Medicall Affairs for Immuno-Oncology, at Merck, West Point, Pennsylvania. '06 Edward Scanzano has joined the R&D Staff of CloudCath as Head of Software Development. CloudCath is a developer of outpatient point-of-care wireless diagnostic devices for monitoring sufferers of End Stage renal disease undergoing at-home dialysis through a permanent indwelling catheter. Metabolic changes and infections are detected in the dialysate fluid and the results transmitted to a medical provider who can intervene pre-crisis. CloudCath is a new biomedical start-up company located in San Francisco. '04 Sherry Young was promoted to Associate Professor of Chemistry with tenure at Muhlenberg College, Allentown. As noted in their website, organic chemistry is at the core of Sherry's teaching interests--particularly in the medicinal and biological applications of organic chemistry in the "real world". Her research interests lie at the interface of chemistry and biology and is focused on improving the ability of known drugs to enter the brain by altering their properties (e.g., polarity). '11 Jonathan Rado was just promoted to Product Leader in vaccines Value-Chain Management at Merck (West Point, Pennsylvania. Page 22 · Lehigh University has been named Director of '96 Lori Getts is Vice President, Preclinical and Process Development at Genisphere, Huntington Valley, PA. Genisphere's mission is to provide and develop a unique DNA-based targeted drug delivery system. Lori was a graduate of Lehigh under a cooperative program our Department of Chemistry operated with Fox Chase Cancer Center (Philadelphia) in which biochemistry students wishing a more clinically-oriented research experience could conduct their research at Fox Chase '04 Lee Schaller was recently recognized by Glaxo Smith Kline for the completion of 25-years of service to the company. Lee commenced his career with GSK as a medicinal chemist and has advanced to Core Consultant for the Strategy Realization Office, the corporate group that manages development of IT software. Three recent Lehigh PhD graduates have been hired as Research Scientists by Croda USA, the American arm of the British specialty company, Croda International. The firm has interests in cosmetics, personal care, agrochemicals, and oleochemicals and has major locations in Edison, NJ, and Atlas Point, Delaware. Croda USA recently landed a large contract to develop and manufacture candidate excipients for the new Pfizer Covid-19 vaccine. Lehigh chemists Peter Kaplan (PhD 2017), Tesia Chciuk (PhD 2017), and recent grad Caroline Bartulovich (PhD 2020) have all been brought on-board to help with the vaccine and related product R&D. Kaplan did his dissertation under Professor Vicic, while Chciuk and Bartulovich were in Professor Flowers’ group.
RkJQdWJsaXNoZXIy MTA0OTQ5OA==